SCHEMBL30184662

SCHEMBL30184662

C#CCNc1ccc(P(=O)(C2CC2)C2CC2)cc1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 2/20 0.36
▸ PDE4D Q08499 2/20 0.36
▸ MAPT P10636 4/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ LMNA P02545 2/20 0.32
▸ HPGD P15428 2/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ IDH1 O75874 1/20 0.31
▸ PDE4A P27815 1/20 0.31
▸ PDE4C Q08493 1/20 0.31
▸ INSR P06213 1/20 0.30
▸ IGF1R P08069 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25033478 1.00 PDE4B (0.36) PDE4BPDE4DMAPTALDH1A1KDM4E
SCHEMBL30832685 0.94 PDE4B (0.39) PDE4BPDE4DMAPTALDH1A1KDM4E
SCHEMBL30871276 0.83 INSR (0.41) MAPTALDH1A1KDM4EPOLBGAA
SCHEMBL25033063 0.83 INSR (0.41) MAPTALDH1A1KDM4EPOLBGAA
SCHEMBL30184470 0.81 LMNA (0.35) PDE4BPDE4DMAPTALDH1A1KDM4E
SCHEMBL25030907 0.81 LMNA (0.35) PDE4BPDE4DMAPTALDH1A1KDM4E
SCHEMBL25033612 0.75 INSR (0.32) MAPTALDH1A1KMT2AINSRIGF1R
SCHEMBL30184541 0.75 INSR (0.35) INSRIGF1RALK
SCHEMBL26983715 0.74 ALDH1A1 (0.47) MAPTALDH1A1POLBGAAHTT
SCHEMBL25032398 0.72 LRRK2 (0.49) MAPTALDH1A1KDM4EPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400591-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-12-05 — — US disclosed
EP-4384510-A1 COMPOUNDS TARGETING MUTANT OF P53 Jacobio Pharmaceuticals Co., Ltd. (CN) 2024-06-19 — — EP disclosed
WO-2023016434-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400591-A1 COMPOUNDS TARGETING MUTANT OF P53 TP53, TP53BP1, MDM2 PDE4B 3469/4885PDE4D 4154/4885MAPT 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback